Results 151 to 160 of about 287,217 (298)

In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency [PDF]

, 1992
Fatih M. Uckun, Carlos Manivel, Doungmo Wakem Yannick Arthur, LM Chelstrom, D Finnegan, L Tuel-Ahlgren, JD Irvin, Damian E. Myers, Robert Günther   +8 more
openalex   +1 more source

A practical approach to panel design, validation, and interpretation for the evaluation of T‐cell neoplasms by flow cytometry

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract The diagnosis of T‐cell neoplasms remains one of the most challenging areas in hematopathology due to the immunophenotypic heterogeneity and subtle aberrancies often present in these entities. This “Best Practice” manuscript provides a practical framework for laboratories to design, validate, and interpret immunophenotyping studies of immature
Jean Oak, Felipe Magalhaes Furtado, Katherine A. Devitt, Pedro Horna, Jonathan R. Fromm, Lianqun Qiu, Andrea Illingworth, Jolene Cardinali, Wolfgang Kern, Ahmad Al‐Attar, Min Shi   +10 more
wiley   +1 more source

Haploidentical Transplant in Radiosensitive Severe Combined Immunodeficiency Disease. [PDF]

Cureus, 2023
Saini M, Khadwal AR, Roy SS, Pandiarajan V, Malhotra P.   +4 more
europepmc   +1 more source

Short-limb skeletal dysplasia with severe combined immunodeficiency [PDF]

, 2020
Inserm
openalex   +1 more source

Rodent monocyte‐derived macrophages do not express CD163: Comparative analysis using macrophages from living boreoeutherians

Developmental Dynamics, EarlyView.
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito, Yukio Fujiwara, Yasuka L. Yamaguchi, Satomi S. Tanaka, Kyoko Miura, Yoshiyuki Hizukuri, Kyoko Yamashiro, Yasuhiro Hayashi, Yuta Nakashima, Yoshihiro Komohara   +9 more
wiley   +1 more source

BCL10 Deficiency Presenting as Severe Combined Immunodeficiency Escaping Newborn Screening. [PDF]

J Clin Immunol, 2023
Salou S, Voelkl S, Keller B, Ehl S, Naumann-Bartsch N.   +4 more
europepmc   +1 more source

Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex

, 2009
Michelle A. King, Laurence Covassin, Michael A. Brehm, Waldemar J. Racki, Todd Pearson, Jean Leif, Joseph Laning, William L. Fodor, Oded Foreman, Lisa Burzenski, Thomas H. Chase, Bruce Gott, Aldo A. Rossini, Rita Bortell, Leonard D. Shultz, Dale L. Greiner   +15 more
openalex   +1 more source

The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018) [PDF]

, 2018
Christopher C. Dvorak, Élie Haddad, Rebecca H. Buckley, Morton J. Cowan, Brent R. Logan, Linda M. Griffith, Donald B. Kohn, Sung‐Yun Pai, Luigi D. Notarangelo, William T. Shearer, Susan E. Prockop, Neena Kapoor, Jennifer Heimall, Sonali Chaudhury, David C. Shyr, Sharat Chandra, Geoff D.E. Cuvelier, Theodore B. Moore, Shalini Shenoy, Fred Goldman, Angela R. Smith, Gauri Sunkersett, Mark Vander Lugt, Emi Caywood, Troy C. Quigg, Troy R. Torgerson, Shanmuganathan Chandrakasan, John Craddock, Blachy J. Dávila Saldaña, Alfred P. Gillio, Evan Shereck, Victor Aquino, Kenneth B. DeSantes, Alan P. Knutsen, Monica S. Thakar, Lolie C. Yu, Jennifer M. Puck   +36 more
openalex   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Severe Combined Immunodeficiency (SCID) and Its New Treatment Modalities. [PDF]

Cureus, 2023
Wadbudhe AM, Meshram RJ, Tidke SC.
europepmc   +1 more source